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CHAPTER 1: LITERATURE REVIEW 
Leishmania spp. are parasitic protozoa that infect an estimated 1.5 to 2 million people 
annually in 88 countries. Currently no effective vaccines are available, and although 
treatments exist emergence of drug resistant strains is a major concern. Leishmania spp. 
cause a range of diseases varying in severity from the self-healing skin lesions of the 
cutaneous form to the potentially fatal visceral form. The cutaneous form is considered a 
childhood illness in endemic areas, while the visceral form infects 500,000 people annually. 
Leishmania has a digenetic life cycle, which alternates between a mammalian host 
and a sandfly vector. The parasites are introduced to the bloodstream of the mammal by the 
bite of an infected sandfly. In the mammal, the parasites are called amastigotes and live and 
reproduce inside the phagolysosome of macrophages. As the cells divide and multiply in the 
macrophage, they eventually cause the macrophage to burst, releasing free amastigotes that 
can then infect more macrophages. When a sandfly then takes a bloodmeal from an infected 
mammal, the ingested parasites infect the sandfly. 
Once in the sandfly, the parasites change from the amastigote to the promastigote 
form. These promastigotes must then escape the chitinous peritrophic matrix that surrounds 
the bloodmeal. Once outside of the peritrophic matrix, the promastigotes travel up the 
midgut to the cardiac valve. Normally, the cardiac valve is responsible for allowing the 
unidirectional flow of blood during a bloodmeal. In infected sandflies flow is bidirectional 
due to damage to the cardiac valve caused by the parasites and parasite accumulation. This 
allows the infective promastigotes to be regurgitated into the mammal when an infected 
sandfly takes a bloodmeal (reviewed in Schlein, 1993). 
During the 1-3 weeks in the fly gut, or in laboratory cultures in the absence of 
sandflies (Sacks and Perkins, 1984 ), parasites undergo a process termed metacyclogenesis. 
Metacyclogenesis is the process by which the promastigotes differentiate from a non-
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infectious procyclic form to a highly infectious metacyclic form. Notable changes that occur 
in metacyclogenesis are modifications to infectivity, morphology, replication state, and 
surface biochemistry. The procyclic form replicates by binary fission, is rounded with a 
short flagellum, and has low infectivity to mammals. The metacyclic form does not 
replicate, is highly motile with an elongated shape and a long flagellum and is highly 
infectious to mammals. The biochemical changes on the surface include an increase of 
surface glycoprotein GP46 in the metacyclic forms, as well as a change in the structure of 
surface lipophosphoglycan (Beetham et al. 1997, Sacks et al. 1992 McConville et al. 1990). 
The surface glycoprotein GP63 has three forms, one is expressed constitutively, one only in 
procyclic promastigotes, and the other only in metacyclic promastigotes (Roberts et al., 
1995). 
Although many proteins, including the surface proteins noted above, have been 
characterized to be differentially expressed during parasite development, and although these 
genes are transcribed by RNA polymerase II (i.e. a-amanitin sensitive), no promoters for 
RNA polymerase II have been found in Leishmania spp. All differentially expressed genes 
characterized thus far are constitutively transcribed on polycistronic mRNAs. These 
polycistronic mRNAs are trans-spliced with a splice leader RNA, which adds an identical 
splice leader RNA sequence to the 5' end of all mature mRNAs. Poly-adenylation of the 
mRNAs is coupled with the addition of the splice leader to the downstream gene, as shown in 
experiments where shortening or lengthening of the intergenic region between the poly-
adenylation site of one gene and the splice leader site of the downstream gene results in a 
shift of the poly-adenylation site of the upstream gene corresponding to the insertion or 
deletion (reviewed in Ullu and Nilsen, 1995). 
GP46, GP63 and a heat shock protein (HSP83) are among the best characterized of 
developmentally regulated genes in Leishmania. For all of these genes, modulation of the 
steady state levels of the mRNAs requires RNA elements contained within their 3' 
untranslated region (Beetham et al. 1997, Myung et al, 2002, Shapira et al., 2001, 
Ramamoorthy et al., 1992). Interestingly, the recent sequencing of chromosome 1 in L. 
major showed that all predicted open reading frames were arranged in the same direction 
starting near the center of the chromosome, suggesting there may be as few as two 
transcription start sites on this 1 Mb chromosome (Myler et al. 1999). 
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The lipophosphoglycans (LPGs) are the most abundant molecule on the surface of the 
parasites. The LPGs have four domains, which are a phosphatidylinositol anchor, a glycan 
core, disaccharide phosphate repeat units, and a small oligosaccharide cap. The LPG of L. 
donovani has been shown to double the length of the repeats in metacyclic promastigotes 
(Sacks et al. 1995). It has also been shown that in Leishmania major the LPGs of metacyclic 
promastigotes have galactose side chains that are capped with arabinose, while in procyclics 
the terminal sugars are galactose (McConville et al. 1992). 
GP63 (also called MSP) is a surface glycoprotein that is the second most abundant 
surface molecule and has three forms based on patterns of expression. One form is expressed 
constitutively, one only in logarithmically growing promastigotes, and the other only in 
stationary phase promastigotes. GP63 has been shown to be a serine protease with a wide 
range of substrates, including serum albumin, hemoglobin, C3, immunoglobulin G and rat 
liver lysosomal proteins (Chaudhuri and Chang, 1988). Most importantly to this work, it has 
been determined that GP63 degrades C3 into a form antigenically similar to iC3b 
(Brittingham et al. 1995), which is an inactive form of C3 that prevents the complement 
cascade from continuing through to the formation of the membrane attack complex but can 
promote the phagocytosis of the parasite by macrophages. 
GP46 (also called M-2 or PSA) is a surface glycoprotein that is present in all 
Leishmania species studied so far except for members of the L. braziliensis complex 
(McMahon-Pratt et al. 1992) and is a multicopy gene that accounts for approximately 1-2% 
of the total membrane protein in metacyclic cells (Kahl and McMahon-Pratt 1987). All 
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GP46 sequences determined so far have a serine/threonine rich region, 3-13 leucine-rich 
repeats of 24-25 amino acid residues, a hydrophobic amino-terminal that signals for 
translation on the rough endoplasmic reticulum, and a carboxyl-terminal which is most likely 
cleaved when the protein is attached to a glycolipid anchor (Jimenez-Ruiz et al. 1998). 
Although leucine rich repeat regions are believed to play a role in protein-protein 
interactions, GP46 is not homologous to any protein with a known function. Immunization 
with GP46 has been shown to be protective against Leishmania amazonensis infection in 
rodent models of disease (Champsi and McMahon-Pratt, 1988; McMahon-Pratt et al. 1993), 
but until now a function for this protein has not been determined. 
GP46 is encoded by a gene family containing multiple non-identical copies of GP46 
genes that are arranged in clusters (McMahon-Pratt et al. 1992; Beetham et al. 1997). 
Northern blot analyses in Leishmania chagasi have demonstrated two bands of 2.8 kb and 4.8 
kb that increase over 30-fold in abundance as parasites change from procyclic to infective 
metacyclic promastigotes. It is believed these are the products of two classes of GP46 genes, 
gp46A and gp46B (Beetham et al., 1997). Western blot analysis with total lysates of L. 
chagasi show a similar increase in two bands of 44 and 60 kDa (unpublished data and 
Chapter 2). 
In the lab, Leishmania spp. are maintained by a series of alternate passages through 
hamsters and culture. In culture, growth and development mimics what is observed in the 
sandfly vector in terms of replication, infectivity and morphology (Sacks and Perkins, 1984). 
However, without passage through a hamster, parasites become attenuated (Howard et al. 
1987, Nolan and Herman, 1985, De and Roy, 1999). These high passage parasites are much 
less capable of causing infections in rodents or in isolated macrophages, expression of GP63 
is perturbed (McGwire and Chang, 1994), and expression of GP46 ceases (unpublished data, 
Chapter 2). High passage cells still undergo the morphological change from round to long 
and slender promastigotes. 
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One of the first host anti-microbial immune mechanisms the promastigotes encounter 
when inoculated into a mammalian host is complement mediated lysis (CML). Three 
different pathways can activate complement: classical, mannose-lectin binding, and 
alternative. All three pathways can have the same end result of the formation of a membrane 
attack complex, which is a ring of proteins that punctures the membrane, forming pores and 
killing the cells. The alternative pathway is activated by the parasite surface and does not 
rely on recognition of the parasite by antibodies, making it an innate immune response. The 
classical pathway is dependent on antibody recognition. 
It is well documented that many Leishmania species activate complement via the 
alternative pathway, although a few species have been shown to also activate the classical 
pathway (Mosser and Edelson 1984, Mosser et. al. 1986, Dominguez 2001). While procyclic 
promastigotes of all Leishmania spp. are sensitive to CML, metacyclic promastigotes are 
differentially sensitive to CML. It has been demonstrated that L. panamensis and L. 
donovani metacyclic promastigotes are resistant to CML while L. major metacyclic 
promastigotes are susceptible to CML (Franke et al. 1985). 
In Leishmania spp., roles for GP63 and LPG in resistance to complement mediated 
lysis have both been studied. As stated earlier, GP63 has been shown to cleave C3 into a 
form antigenically similar to iC3b (Brittingham et al., 1995). In this same study it was 
determined that L. amazonensis deficient in GP63 expression or that expressed a 
proteolytically inactive form of the enzyme were susceptible to lysis by normal guinea pig 
serum. The parasite line deficient in GP63 expression was transfected with an expression 
vector containing the GP63 open reading frame, and these transfectants showed a significant 
increase in survival in 20% normal guinea pig serum. It was also shown that GP63, both 
native and proteolytically inactive, promoted opsonic complement fixation and binding to the 
human complement receptors CRl and Mac-1 which may facilitate invasion of macrophages. 
However, GP63 is not solely responsible for complement activation by these parasites 
(Brittingham et al., 1995). 
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The LPGs of L. major are also believed to play a role in resistance to complement 
mediated lysis. The LPG of both log and stationary L. major are the main C3 acceptor of the 
parasites (Puentes et al. , 1988). In both log and stationary cultures a membrane attack 
complex forms, but in stationary phase cells the complex is shed from the surface of the 
parasite and does not cause lysis (Puentes et al., 1990). It is believed that this shedding is 
due to the elongation of disaccharide repeats in the LPG in stationary phase, and this is 
similar to a mechanism of complement resistance in Salmonella that is due to long 0-
polysaccharide side chains on lipopolysaccharide molecules (Joiner et al., 1982). 
Due to the abundance of GP46 on the surface of the infective promastigote 
membrane, the conservation of GP46 among Leishmania spp., and the roles of other 
Leishmania surface proteins in resistance to CML, we hypothesized that expression of GP46 
plays a role in resistance to CML. We tested this hypothesis by re-expression of GP46 in L. 
chagasi promastigotes that had been serially passed in culture and testing their resistance to 
complement mediated lysis using normal human serum. 
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CHAPTER 2. LEISHMAN/A CHAGASI SURFACE GLYCOPROTEIN GP46 
FUNCTIONS IN PARASITE RESISTANCE TO LYSIS BY COMPLEMENT. 
A paper to be submitted to Molecular and Biochemical Parasitology 
Leslie M. Lincoln, Jeffrey K. Beetham 
Abstract 
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The mRNA for GP46, an abundant surface glycoprotein of most Leishmania spp., is 
expressed at high levels only in infectious Leishmania chagasi promastigotes. To investigate 
a possible role for GP46 in infectivity we analyzed the relationship between GP46 and 
resistance to complement-mediated lysis (CML). L. chagasi promastigotes passed for 2-3 
weeks in culture were about 9-times more resistant to CML (in the presence of 25 and 50% 
human serum) when in stationary phase of growth than in logarithmic phase of growth. Cells 
passed for >100 weeks were extremely sensitive to CML regardless of the phase of growth. 
GP46 expression levels paralleled CML resistance phenotype: low to non-detectable in 
higher passage cells (cells passed for 15-18 weeks, or for >100 weeks) and in low passage 
cells in logarithmic growth phase. Earlier studies with L. chagasi reported the identification 
of GP46A and GP46B coding sequences, and these varied mainly in the number of leucine 
rich repeats found in the amino-terminal half of the predicted protein sequences. GP46A and 
GP46B were re-expressed in higher passage cells transformed with pX~GAL2 plasmids that 
contained GP46 coding sequence in place of ~-galactosidase coding sequence. These higher 
passage cells were significantly more resistant to CML (p<0.01 when incubated with 25 and 
50% serum) as compared to control cells transfected with the unmodified pX~GAL2 
plasmid: at 50% serum, about 80% versus 20% survival in the controls. Levels of CML 
resistance in the GP46-expressing higher passage cells approached that seen in low passage 
stationary phase cells. The data support a role for GP46 in evasion of lysis by complement. 
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Introduction 
Leishmania spp. are protozoan parasites that infect a variety of vertebrates, including 
1.5-2 million people annually. These parasites cause a wide range of diseases, collectively 
called leishmaniases, that present as self-healing skin lesions (cutaneous leishmaniasis), 
destroyed mucous membranes (mucocutaneous leishmaniasis), and potentially fatal 
involvement of internal organs including the spleen and liver (visceral leishmaniasis). 
Leishmania spp. are digenetic, alternating between an amastigote form in the mammalian 
host and a promastigote form in the sandfly vector. 
Through a process called metacyclogenesis, promastigotes undergo a series of 
developmental changes while in the sandfly vector that result in the formation of highly 
infectious metacyclic promastigotes (Schlein, 1993). Metacyclogenesis results in changed 
morphology, replicative state, infectivity to mammals and surface biochemistry. These 
changes are also observed in vitro as parasites progress from logarithmic (non-infectious to 
mammals) to stationary (highly infectious to mammals) phase of growth in liquid culture 
(Sacks and Perkins, 1984). Among the surface biochemistry changes associated with 
metacyclogenesis are an increased length of phosphoglycan repeats in lipophosphoglycan 
(LPG) (Sacks et al., 1995), the expression of different forms of the surface protease GP63 
(Roberts et al., 1995), and increased expression of surface glycoprotein GP46 (Beetham et 
al., 1997). 
When metacyclic promastigotes are passed into the bloodstream of a mammal upon 
bite of an infected sandfly, one of the first immune mechanisms encountered is complement-
mediated lysis (CML). All Leishmania species studied are sensitive to CML in the 
logarithmic phase of growth, but sensitivity is variable when in the stationary growth phase. 
For example, stationary growth phase Leishmania panamensis and Leishmania donovani are 
resistant to CML, but Leishmania major is not (Franke et al., 1985). 
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Studies have shown the potential importance of two abundant surface molecules, LPG 
and GP63 (also known as major surface protease or MSP) to promastigote resistance to CML 
(Brittingham et al., 1995; Puentes et al. , 1990). The lengthening of LPG is hypothesized to 
function in resistance to CML by causing shedding of the membrane attack complex, the 
complex by which CML is effected, from the parasite surface (Puentes et al., 1990). GP63 is 
thought to function by proteolytically cleaving complement factor C3b to a form that is 
unable to support formation of the membrane attack complex (Brittingham et al., 1995). 
Although, as noted above, growth of promastigotes in culture is similar to growth in 
the fly, studies have shown that repeated passage in culture attenuates parasite infectivity to 
cultured macrophages and animals (Howard et al., 1987; De and Roy, 1999; Nolan and 
Herman, 1985). Molecular events that are associated with this attenuation are an increase in 
galactosyl transferase activity in high passage promastigotes (De and Roy, 1999), and an 
increased sensitivity to CML (Howard et al., 1987). 
GP46 (also known as parasite surface antigen or PSA), like GP63 and LPG, is an 
abundant surface macromolecule, and accounts for 1-2% of the total membrane protein in 
metacyclic Leishmania amazonensis promastigotes (Kahl and McMahon-Pratt, 1987). GP46 
is found in all Leishmania spp. examined except members of the Leishmania braziliensis 
complex (McMahon-Pratt et al., 1992). Where characterized, GP46 is encoded by multiple 
non-identical genes (McMahon-Pratt et al., 1992, Beetham et al., 1997). In Leishmania 
chagasi, the steady state level of GP46 mRNA increases over 30-fold as the parasites grow to 
stationary phase (Beetham et al., 1997), but GP46 mRNA expression is reduced to 
undetectable levels after repeated passage of promastigotes in culture. A function for GP46 
has not been previously determined, although the protein does contain leucine-rich repeats of 
24-25 residues which have been shown in other proteins to function in protein-protein 
interactions (Jimenez-Ruiz et al., 1998). Because GP46 mRNA abundance in L. chagasi is 
high only in infectious promastigotes we hypothesized a function for GP46 in resistance to 
complement mediated lysis. 
Materials and Methods 
Maintenance of Leishmania cultures 
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L. chagasi promastigotes were maintained as described in culture at 25°C in a 
modified minimum essential media (HOMEM) supplemented with hemin and heat-
inactivated fetal calf serum (Ramamoorthy et al., 1992). Promastigotes were seeded at a 1 X 
106 cells/ml and harvested by centrifugation in logarithmic or stationary phase of growth, 
which was determined by morphology and cell concentration (Zarley et al., 1991). For the 
purpose of experiments reported here, logarithmic phase cells were harvested when culture 
concentrations were 0.75-1.0 X 107 cells/ml, which occurred 2.5-3.5 days after seeding the 
culture. Stationary phase cells were collected after seven days in culture, which was two 
days after cells reached maximum density. HOMEM used for cultures of transformed 
promastigotes was supplemented with 50µg/rnl Geneticin® (Invitrogen, Carlsbad, CA). 
Construction of Plasmids 
The isolation and sequencing of L. chagasi cDNA for GP46A and a lambda-phage 
genomic clone of GP46B was described previously (Beetham et al. , 1997). The first six 
residues of the deduced proteins are identical: MALCVR. Expression vector pXBGAL2, 
kindly provided by Stephen Beverley (LeBowitz et al., 1990), was digested with Bam HI 
followed by mung bean nuclease treatment to blunt end the DNA to eliminate the entire B-
galactosidase coding sequence except for the first six nucleotides that code for MA amino 
acid residues. Subsequent digestion with Xba I, which cleaves 3' to the original B-gal insert, 
yielded a pXBGAL derivative vector suitable for directional cloning. The coding sequence 
of GP46A and B were amplified by PCR using forward primer 
16 
5'gcatacgtactgtgcgtgcgtcggctggt3' (GP46A and B) and reverse primers 
5'ggttctagatcacgccgccagccccacgc3' (GP46A) and 5' gctactagttcacgtcgccagccccacg3' (GP46B). 
The forward primer contains a Sna BI restriction endonuclease site (Sna BI produces blunt-
ended products), while the reverse primers contain sites that allow ligation to Xba /-digested 
sites (the GP46A and B primers include Xba I and Spe I sites respectively). Following PCR 
amplification (35 cycles of 94 °C 1 min., 58°C 1 min., 72°C 1.5 min.), PCR products were 
digested with Sna BI and Xba I (GP46A) or Spe I (GP46B), band isolated on low gelling 
temperature agarose, and ligated into pX~GAL2-derived vector previously prepared as 
described above. Due to the Sna BI 1/2 site, the resulting constructs code for GP46A and B 
that contain a new Valine residue at position three (MA VLCVR). Inserts were verified by 
sequencing (University of Iowa and Iowa State University DNA and Sequencing Facilities 
using Applied Biosystems Model 377 Prism DNA sequencers). 
Generation of transfectants 
L. chagasi promastigotes that had been in culture for less than three weeks after 
initiating the culture using hamster-derived amastigotes were stably transfected by 
electorporation with pX~GAL2, pXGP46A, or pXGP46B. Clones were isolated on semi-
solid medium supplemented with 50 µg/ml Geneticin® (Invitrogen, Carlsbad, CA) according 
to published protocol (LeBowitz, 1994). Clonal isolates were then serially passed. 
PCR Confirmation of transfectants 
Transfectants containing the pXGP46A or pXGP46B plasmids were confirmed using 
PCR. Plasmids were isolated from transfected parasites using the alkaline lysis miniprep 
method (Sambrook and Russell, 2001). PCR reactions used 1µ1 of DNA isolated from 
transfectants as the template and other components as specified in the protocol for Platinum® 
Tag DNA polymerase (Invitrogen, Carlsbad, CA). Reactions consisted of 30 cycles of 94 °C 
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1 minute, 50°C 1 minute, and 72°C 2 minutes. The DNA used as positive controls were 
pXGP46A and pXGP46B. The forward primer for GP46A and B analysis was 5'-
gtggtctgcgatgccga-3' . The reverse primer for all reactions, designed using the sequence 
located 3' to the GP46 insert sites in the plasmid vector, was 5'-caccccaggctttacac-3'. 
Negative control reactions excluded template DNA, the forward primer, or the reverse primer 
from the reaction. Products were analyzed by agarose gel electrophoresis. 
Preparation of human serum 
Human blood was drawn from naive, adult humans in serum tubes and incubated at 
room temperature for 45 minutes, then on ice for 45 minutes. Coagulated blood was 
centrifuged for 15 minutes at 2000Xg at 4 °C. Serum was then allocated into eppendorf tubes 
for single use and stored at -80°C until use. If necessary, serum was heat inactivated by 
incubation at 56°C for 15 minutes. 
Complement Lysis Assay 
Promastigotes were incubated at 37°C for 30 minutes in phosphate-buffered saline 
(PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HP04, 2 mM KH2P04, pH7.4) containing 0%, 
12%, 25%, or 50% normal human serum with a final cell density of 3.5 X 107 cells/ml. After 
incubation, samples were immediately diluted 100-fold with ice-cold PBS and intact, motile 
promastigotes counted by light microscopy on a hemocytometer. Results are expressed as 
the percentage of live promastigotes as compared to control reactions that contained no 
serum. For statistical analysis, means from the pXGP46A and pXGP46B transfectants were 
compared to pX~GAL2 clones using a one-way ANOV A followed by a Dunnett's test using 
pX~GAL2 as the control. 
Western Analysis 
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Total lysates of parasites were separated by SDS-polyacrylamide gel electrophoresis 
(Laemlli, 1970) using a 10% separating gel, then electro-transferred to nitrocellulose 
membranes using a semi-dry transfer apparatus at 2 mA/cm2 for 1 hour in Towbin buffer 
(0.025 M Tris, 0.192 M glycine, 20% methanol, pH 8.3). Blots were incubated at 25°C (i) 
for 1 hour in PBS-T (PBS plus 0.05% Tween-20) supplemented with 5% powdered milk, 
then (ii) for 1 hour in PBS-T supplemented with either primary rabbit antisera to GP46 
diluted 1 :2000 or a monoclonal antibody to tubulin diluted 1 :5000. After washing the blots 
in PBS-T 4 times for 15 minutes per wash, appropriate secondary HRP-conjugated (anti-
rabbit or anti-mouse) antibody (Pierce, Rockford, IL) was added at a 1 :30,000 dilution in 
PBS-T and incubated for 1 hour at 25°C. Blots were then washed 4 times as above, and 
antibody binding was visualized by enzyme linked chemiluminescence per instructions 
(SuperSignal ®, Pierce, Rockford, IL). Blots initially probed with antisera to GP46 were 
stripped by incubation at 37°C for 30 minutes in lM glycine to be reprobed with the tubulin 
monoclonal antibody. 
Anti-GP46 antisera was isolated from rabbits immunized with a recombinant GP46A-
Glutathione S-transferase (GST) protein conjugate produced in Escherichia coli using the 
pGEX4-T-1 plasmid system (Amersham Pharmacia Biotech, Piscataway, NY). A cDNA 
clone containing a GP46A 3'-untranslated region plus all but the first 112 bases of the 
GP46A coding sequence was previously described (Beetham et al., 1997). The insert of that 
clone was bordered by Eco RI (5' end) and Xho I (3' end) restriction endonuclease sites, 
which allowed its cloning, in-frame, into the same restriction sites of pGEX4Tl. Standard 
procedures were used to purify the recombinant protein antigen from E. coli lysate 
(Amersham Pharmacia Biotech, Piscataway, NY) by binding to, followed by elution from, a 
glutathione-based column, then separation by preparative SDS-PAGE. 
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The tubulin-specific monoclonal antibody was developed by M. Kymkowsky and was 
obtained from the Developmental Studies Hybridoma Bank maintained by The University of 
Iowa, Department of Biological Sciences, Iowa City, IA 52242. 
Results 
Expression of GP46 in high passage L. chagasi promastigotes 
Earlier studies showed that GP46 rnRNA levels in low passage L. chagasi 
promastigotes increase about 30-fold in cells at stationary phase of growth (Beetham et al., 
1997), and this increased rnRNA abundance correlates with increased abundance of the 
protein (data not shown). When cells were serially passed 15 times, GP46 levels in 
stationary phase promastigotes declined by 85% (Fig. 1, lane 3 versus 1). Cells passed 
weekly for more than 2 years in culture had no detectable GP46 when analyzed using the 
same analytical procedures used here (data not shown). 
Expression plasmids were made by replacing the coding sequence of ~-galactosidase 
with that of either GP46A or GP46B in the expression construct pX~GAL2, and constructs 
were confirmed by sequencing the entire inserts and by restriction endonuclease digestion. 
L. chagasi promastigotes were transfected within their first three passages in culture, then 
clonal isolates were carried through to higher passage under drug selection. Presence of the 
desired plasmid was confirmed by PCR (Figure 2). In this analysis, PCR amplification with 
a single forward primer specific to GP46A and B, and a reverse primer specific to a region of 
the vector downstream of the open reading frame, yielded products of the expected size (710 
bp for pXGP46A and 860 bp for pXGP46B plasmids). The 150 bp difference in length of 
these products is due to the longer coding sequence of GP46B. PCR of positive controls 
yielded the expected 710 and 860 bp products (Fig. 2) that were not present in negative 
controls (data not shown. 
Western analysis of transfectants using antisera raised against GP46 demonstrated 
that relatively high levels of GP46 were produced in cells passed 15 times that contained the 
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plasmids bearing the GP46A or GP46 B coding sequences (Fig. 1, lanes 4 and 5, the 44 and 
60 kDa bands). By comparison, GP46 was almost non-detectable in cells at the same 
passage that contained the control plasmid that bears the coding sequence for ~-galactosidase 
instead of GP46 (Fig. 1, lane 3). On these blots a minor protein migrating at about 54 kDa 
was detected with the GP46 antisera, but levels of this protein did not increase in cells 
transfected with plasmids bearing GP46 coding sequence. 
To estimate the relative amount of GP46 present in the cells, GP46 signals were 
normalized to that of tubulin. GP46 levels were determined by western blot using anti GP46 
antisera (Fig. 1, upper panel). Bound GP46 antibodies were stripped, then tubulin levels 
were determined by reprobing the blot using a monoclonal antibody to tubulin (Fig. 1, lower 
panel). Densitometric analysis of the autoradiographs resulting form these experiments 
indicated the tubulin signal varied less than 35% among all lanes. After using tubulin signals 
to normalize GP46 signals for between-lane loading differences, GP46 levels in passage 15 
cells transfected with pXGP46A and pXGP46B were seen to be 1.5- and 3.7-times that of 
low passage cells. The analysis also indicated that GP46 levels in cells transfected with 
pXGP46A and pXGP46B were 9- and 24-times that of cells transfected with control 
(pX~GAL2) plasmid (Fig. 1, lanes 4 and 5 compared to 3). 
Resistance of parasites to complement mediated lysis 
L. chagasi low passage promastigotes are very resistant to CML when in stationary, 
but not logarithmic, growth phase (Fig. 3a). Stationary phase promastigotes were 
approximately 9-times more resistant to CML at 25% and 50% serum than were logarithmic 
phase promastigotes. Promastigotes passed over 100 times were highly susceptible to CML 
when in either logarithmic or stationary growth phases (Fig. 3b). At 12 percent serum, 
serially passed cultures were more sensitive to CML than were low passage cells (Fig. 3a 
versus b). 
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Expression of GP46 in higher passage cells confers resistance to CML (Fig. 3c). 
Stationary phase cultures of transfected L. chagasi promastigotes (including the transfectants 
for which GP46 levels are shown in Fig. 1) were assayed for sensitivity to CML after 15-18 
passages (Fig. 3c). Four clonal isolates of each transfectant were assayed in increasing 
concentrations of normal human serum. In the presence of 25% and 50% serum, 
transfectants that expressed plasmid-encoded GP46 were significantly more resistant to CML 
than were transfectants transfected with control plasmid (p <0.01). Approximately 77% of 
GP46-expressing cells survived treatment with 50% serum, while only about 22% of the cells 
transfected with pXl)GAL2 survived the same treatment. Thus increased resistance to CML 
corresponds to expression of GP46 in the transfectants (Fig. 1). While at 25% and 50% 
serum the resistance of control transformants at passage 15-18 to CML was as low as that of 
non-transfected cells that had been passed >100 times, the passage 15-18 cells had greater 
standard deviations. When incubated in 12% serum, no significant difference in resistance to 
CML was seen among the transfectants (p >0.10). Use of heat-inactivated serum in 
experiments with transformed or non-transformed cells resulted in 100% survival at all serum 
concentrations (data not shown). 
Discussion 
This study was designed to test a hypothesized function for GP46 in resistance to 
CML. One initial observation, that low passage L. chagasi promastigotes in stationary 
culture phase become highly resistant to CML (Figure 3a), is similar to previous observations 
of L. panamensis and L. donovani promastigotes (Franke et al., 1985). Additional 
characterization showed that serial passage leads to loss of CML resistance (Fig. 3b) and 
GP46 expression (Fig. 1). Building on these observations, we tested our hypothesis by re-
expressing GP46 in higher passage cells then measuring the sensitivity of the cells to CML. 
This approach is similar to that used by Brittingham et al. in which GP63 was re-expressed in 
high passage L. amazonensis using the same expression vector used in this study 
(Brittingham et al., 1995). 
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The data demonstrate that higher passage cells that re-express GP46 resist CML (Fig. 
3c). However, resistance to CML was not quite restored to the level seen in low passage 
promastigotes. The most likely reason for this is that resistance to CML is a combinatorial 
process that involves multiple surface macromolecules that, like GP46, are affected by serial 
passage. Other surface-associated macromolecules thought to be important to CML 
resistance are LPG and GP63 (Brittingham et al., 1995, Puentes et al., 1990). We and others 
have observed that serially passed L. chagasi and L. amazonensis promastigotes have 
reduced GP63 expression, (Roberts et al., 1995; Liu and Chang, 1992), and serially passed L. 
donovani have increased galactosyl transferase activity and terminally exposed galactose 
residues (De and Roy, 1999). 
The data presented here, in combination with the earlier studies of GP63 and LPG 
functions, supports a model in which resistance of L. chagasi promastigotes to CML may be 
achieved by several different mechanisms that may work additively or synergistically. An 
important question is whether the capacity in vivo for GP46 to confer CML resistance 
translates to a biological function of GP46. Although experiments represented here relied on 
the approach of gene amplification via an episomal expression system, and alternative 
approach of gene deletion would be another way to validate the biological relevance to our 
posited GP46 function. For example, if GP46 expression could be abrogated in low passage 
cells, then studies could determine the corresponding effects on infectivity. Unfortunately, 
because GP46 is a multi-copy gene where examined (McMahon-Pratt et al., 1992; Beetham 
et al., 1997), use of gene knockout strategies would be technically very challenging, although 
this approach was used to remove a 20kb genomic region containing seven closely clustered 
msps genes in L. major (Joshi et al, MBP, 2002). RNA interference is an alternative 
approach towards reducing levels of an mRNA. Unfortunately, this technology that works so 
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well in Trypanosoma spp. has not been made to work in Leishmania spp., even when 
attempted by researchers who routinely perform RNA interference experiments with 
Trypanosoma spp. (unpublished, J.E. Donelson). Gene deletion experiments using 
inhibitory RNA techniques will have to wait on perfection of this technology in Leishmania 
spp. 
It is interesting to note that work by Franke et al. demonstrated that at all serum 
concentrations > 10%, L. panamensis stationary promastigotes exhibited greater CML 
resistance than the other species examined, including L. donovani (Franke et al., 1985). 
Furthermore, L. panamensis is a member of the L. braziliensis complex, and studies have 
also indicated that this is the only group of Leishmania spp. examined in which GP46 genes 
or protein have not been detected (McMahon-Pratt et al., 1992). This suggests that in the L. 
braziliensis complex CML resistance due to non-GP46 macromolecules may be high enough 
to have significantly reduced the evolutionary selective pressure that in other complexes 
drove for retention of GP46. Of course, there are alternative hypotheses to explain a loss of 
GP46 in this complex. For instance, since members of this complex develop in the hind-gut 
of the fly vector, while members of other complexes do not, perhaps GP46 is not required for 
parasite development in the fly hind gut but is required for development elsewhere in the fly. 
It is also possible that failure to detect GP46 in the L. braziliensis complex was due to factors 
other than gene absence. At the time the study was done, regulated abundance of GP46 in 
developing promastigotes was an unknown phenomeno,n. Perhaps DNA and protein samples 
from L. braziliensis complex members were taken from cells at a non-GP46-expressing 
growth phase. It is also possible that GP46 genes have diverged sufficiently in the L. 
braziliensis complex to impair their detection with probes made to GP46 of L. amazonensis, 
as were used in the early study. However, this would be a difficult hypothesis to support, 
given that the same probes used to detect GP46 in a variety of Leishmania spp. also 
hybridized to chromosomes of Crithidia fasciculata, a member of the same family 
(Trypanosomatidae) as Leishmania spp. but that diverged prior to when the L. braziliensis 
complex became evolutionarily isolated from other Leishmania complexes. 
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We have not investigated the observed phenomena that cells transfected with 
plasmids containing GP46A or B coding sequences produce 46 and 60kDa proteins (Figure 
1, lanes 4,5). The magnitude of this size difference makes it unlikely that differential 
glycosylation causes the effect. Other possible explanations, including that GP46 is 
covalently linked via non-disulfide linkages to other macromolecules, and that production of 
plasmid-encoded GP46 somehow overcomes the reduced expression of chromosomal GP46 
genes, need to be studied. 
It is also unclear why evolution has conserved the presence of multiple GP46 
genes/protein (McMahon-Pratt et al., 1992, Beetham et al. , 1997). One possibility is that 
resistance to CML of specific vertebrates varies by GP46 gene/protein class. Our 
(unpublished) studies with GP46 of L. chagasi suggest there may be three GP46 gene 
families in this species, based on DNA sequences (and predicted protein coding sequences) 
of multiple GP46 cDNA clones. Future studies can investigate whether individual re-
expression of these three GP46 classes in high passage promastigotes confers variable 
resistance to CML when assayed with serum derived from a range of mammals. 
A mechanism for how GP46 functions in resistance of L. chagasi promastigotes 
remains to be determined in future studies. One possibility is that the heavily glycosylated 
GP46 prevents access of the membrane attack complex to the parasite membrane. Another 
possibility is that GP46 somehow causes shedding of the membrane attack complex from the 
parasite surface, as has peen posited for the CML-resistance activity of LPG (Puentes et al., 
1990). It is also plausible that GP46, possibly through the leucine-rich repeats of the amino-
region, inhibits completion of the complement cascade via protein-protein interactions (i.e. 
with components of the immune system). Analogous examples in which CML is inhibited 
by binding of parasite molecules to host complement components have been 
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hypothesized/implicated in Borrelia burgdorferi, Escherichia coli, Salmonella spp. and 
Streptococcus pyogenes (reviewed in Wiirzner, 1999). Further study of GP46 genes and 
protein, and their function in Leishmania promastigote resistance to CML can address these 
questions. 
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CHAPTER 3. DISCUSSION 
This study supports the possibility of a role for GP46 in resistance of L. chagasi 
promastigotes to complement-mediated lysis. It will be interesting to determine the 
mechanism of this function. A logical place to start would be to determine if GP46 binds to 
any complement proteins, possibly by using purified GP46 bound to a column. Protein-
protein interaction with GP46 would be possible by either the leucine-rich repeat region in 
the amino half of the protein or the serine/threonine and acid rich carboxyl half. 
Construction of the GP46-expression plasmids used here, which included the GP46 
coding sequences but not any GP46-derived UTR sequences, was intended to yield plasmids 
that would constitutively express GP46 when transformed into recipient cells. Omission of 
GP46-UTRs was based on the general knowledge that in Leishmania spp. levels of 
developmentally regulated mRNAs are frequently found to be modulated by post-
transcriptional mechanisms that require cis-acting elements contained within 3'UTR 
sequences (Aly et al., 1994; Nozaki and Cross, 1995; Teixeira et al., 1995; Coughlin et al, 
2000, Kelly et al., 2001; Charest et al., 1996; Quijada et al., 2000, Myung et al., 2002). More 
specifically, studies ofregulated GP46 expression have similarly determined that 3'UTR 
sequences confer GP46-like patterns of expression when appended to coding sequences of 
reporter genes (Beetham et al., 1997; Myung et al., 2002). Therefore, the observation 
(described below) that GP46 was not constitutively produced in high passage cells 
transformed with the GP46-expression plasmids was unexpected. 
Figure 1 is a Western blot showing expression levels of GP46 in high passage 
transfectants and low passage non-transfected promastigotes in logarithmic and stationary 
phases of growth. No, or very little, GP46 was detected in logarithmic phase cells, including 
those that contained plasmids with the coding sequences of GP46 (Fig. la, lanes 4,5). GP46 
(44 and 60 kDa bands) was detected in stationary low passage cells, and in the high passage 
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cells containing plasmids bearing GP46 coding sequences (Fig. 1 b ). Thus in the higher 
passage cells, expression of the GP46 coding sequence, without inclusion of GP46 5'- or 3'-
UTRs in the expression plasmids, yielded the same pattern of expression (low in log phase 
and high in stationary phase) seen in non-transformed low passage cells. 
To determine if the inability to express GP46 in logarithmic phase transfectants is due 
to the 3'UTR of the vector or the to open reading frame of GP46, analysis of ~-galactosidase 
expression in the pX~GAL2 transfectants needs to be conducted. If ~-galactosidase 
expression varies between logarithmic and stationary phases, the regulation in all 
transfectants is most likely due to the 3'UTR of the vector. If ~-galactosidase expression in 
the controls does not differ between logarithmic and stationary phases, the differential 
regulation of GP46 in the vector is most likely due to the coding sequence of GP46, and 
further investigation will be called for. 
Western blots that analyzed low passage stationary phase promastigotes show 
reaction of an antibody to GP46 with two bands migrating at 44 and 60 kDa (Fig. 1). We 
previously hypothesized that these two bands were the result of expression of two different 
GP46 genes with different coding sequences. Therefore, when high passage promastigotes 
were transfected with an expression vector containing a coding sequence for one GP46 gene 
we expected only one band to be re-expressed. Instead, transfectants produced both bands of 
44 and 60 kDa regardless of which GP46 coding sequence was contained in the expression 
plasmid. It will be interesting to determine the nature of this observation. Possible reasons 
are expression of more than one form of GP46 although only one form is expressed by the 
plasmid, post-translational modification, or covalent bonding. Northern analysis of these 
transfectants will reveal if the two bands are the result of one or more GP46 mRNAs. 
Experiments in which the cell proteins are pulse-labeled then precipitated with GP46 antisera 
can determine whether one protein size chases to the other, an indication that one band 
derives from the other. 
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In Leishmania spp. studied, multiple non-identical genes encode GP46 (Kahl and 
McMahon-Pratt, 1987). Why there are multiple copies is an intriguing question. One 
hypothesis, based on the role of GP46 in resistance to complement-mediated lysis, is that 
these different versions function in resistance to CML of different mammalian species. This 
hypothesis can now be tested using the transfectants made here and serum from different 
mammals. An alternate hypothesis is that GP46 has another role within the fly gut that 
necessitates the diversity of genes. 
This study has provided evidence of a function for GP46. These transfectants can 
now be used to further study the mechanism of this resistance and a reason for the existence 
of multiple non-identical GP46 gene copies. This will further our understanding of immune 
evasion and infectivity of Leishmania spp. that will hopefully aid the discovery of new 
treatments or a vaccine for this disease. 
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